Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilon NAC
NCT03652753Phase 4Recruiting
- Sponsor
- University of Missouri
- Start
- Jan 2019
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetylcysteine in pilon fracture (TPF) (2 arms), sponsored by University of Missouri. Primary endpoint: Cartilage Cell Viability. Started Jan 2019; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
pilon fracture (TPF)
Beyond the preview
Go deeper on NCT03652753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03652753.